Executive Conclusion | MIMIC Analytics

Summary

This analysis integrates 24,780 clinical records across admissions, diagnoses, prescriptions, transfers, and procedures from the MIMIC-IV demo cohort. The data describes a high-acuity, older-adult inpatient population with heavy emergency utilization, substantial comorbidity burden, intensive medication management, and active intra-hospital bed movement.

All 100 patients appear across transfer and medication domains; 92 received coded procedures. KPIs from the Databricks business analysis notebook align exactly with the five Gold-layer reporting views, confirming data integrity from lakehouse to Power BI dashboard.

24,780

Total Records

100

Patients

275

Admissions

19.3%

Readmission Rate

5.5%

Mortality Rate

1. Population & Utilization

Metric	Value
Patients	100
Admissions	275 (2.75 per patient)
Average LOS	6.88 days (median 4.85)
30-day readmissions	53 (19.3%)
In-hospital deaths	15 (5.5%)
Top admission type	EW EMER. — 104 (37.8%)
Dominant age band	50–79 — 62% of patients

Conclusion: Utilization is repeat-visit driven — high-utilizer patients account for a disproportionate share of admissions. The cohort is older, emergency-oriented, and clinically complex, with significant post-discharge and chronic-disease management needs.

2. Clinical Profile

Admitting conditions (primary diagnoses)

Coronary atherosclerosis and acute kidney failure lead at 7 admissions each, followed by cerebral aneurysm, NSTEMI, aortic valve disorders, and postoperative infection (4 each). Admissions reflect diverse acute presentations — no single condition dominates.

Comorbidity burden (all diagnoses)

Secondary coding reveals chronic cardiometabolic disease: hypertension (68 records), hyperlipidemia variants (112 combined), hypothyroidism (47), obesity (43), insulin use (37). With 16.4 ICD codes per admission, documentation reflects typical US inpatient coding density.

Conclusion: Patients present with acute cardiac/renal events on a background of chronic metabolic disease. Clinical strategy: dual focus on acute stabilization and long-term cardiometabolic management.

3. Medication & Treatment Intensity

Metric	Value
Prescription records	18,087
Unique drugs	626
Avg prescriptions per admission	72.3
Avg prescription duration	2.71 days
IV route share	45.4% (51%+ incl. IV DRIP)

Top medications: Insulin (915) · 0.9% Sodium Chloride (810) · Potassium Chloride (610) · Furosemide (510) · Metoprolol (371)

Conclusion: Medication exposure is universal and intensive — all 100 patients medicated. Formulary profile confirms acute inpatient care with significant diabetes and cardiovascular management.

4. Hospital Operations

Patient movement

Metric	Value
Transfer events	1,190 (4.3 per admission)
Event mix	TRANSFER 34% · DISCHARGE 23% · ADMIT 23% · ED 20%
Avg transfer duration	51.22 hours
Busiest named unit	EMERGENCY DEPARTMENT — 236 events
Longest unit stay	Medicine/Cardiology Intermediate (~332 hrs)

Procedures

Metric	Value
Procedure records	722
Patients with procedures	92 (92%)
Admissions with procedures	187 (68%)
Top age group	50–64 (286 procedures, 39.6%)

Top procedure codes: Central venous access (02HV33Z, 3897) · enteral nutrition (966) · mechanical ventilation (9671)

Conclusion: Operations reflect a high-intensity inpatient environment — frequent transfers, ED throughput, and invasive support procedures concentrated in the 50–64 age band.

5. Cross-Domain Themes

Theme 1

Emergency-driven, older-adult cohort

EW EMER. = 37.8% of admissions. Patients aged 50–79 = 62%. Insurance: OTHER 54%, Medicare 38%.

Theme 2

Acute on chronic

Primary = cardiac/renal events. Secondary = hypertension, diabetes, hyperlipidemia. Medications = IV fluids + insulin + cardiovascular drugs.

Theme 3

High coding density

~16 diagnoses, ~72 prescriptions, ~4 transfers per admission. Documentation-rich US hospital practice.

Theme 4

Readmission risk

19.3% 30-day readmission. 27.6% discharged to home health. Significant post-acute care needs.

Theme 5

Volume ≠ intensity

EW EMER. drives volume; URGENT/DIRECT EMER. drive longer LOS. Separate throughput from bed-day planning.

6. Data & Analytics Validation

Five Gold reporting views consumed by Power BI and 07_business_analysis. Cross-validation confirms pipeline integrity:

View	Records	Key KPI	Report
`vw_admission_overview`	275	6.88 LOS · 19.3% readmission	Dashboard 1
`vw_diagnosis_analysis`	4,506	16.4 dx/admission · hypertension leads	Dashboard 2
`vw_prescription_analysis`	18,087	72 rx/admission · insulin leads	Dashboard 3
`vw_transfer_analysis`	1,190	4.3 events/admission · ED busiest	Dashboard 4
`vw_procedure_analysis`	722	92% patient coverage · 50–64 leads	Dashboard 4

Platform conclusion: The medallion pipeline is fit for purpose as an end-to-end clinical data engineering demonstration — from raw MIMIC-IV CSV through Databricks Gold to interactive dashboards.

7. Limitations

Demo subset — 100 deidentified patients; not representative of full MIMIC-IV or real-world epidemiology.
Deidentified dates — admission years (2110–2201) cannot be interpreted as calendar trends.
Hospital tables only — no ICU charting, labs, or vitals; administrative, not physiological picture.
Coverage gaps — 25 admissions lack pharmacy records; 8 patients lack procedures.
US coding context — high diagnosis and prescription counts reflect billing practice, not necessarily distinct clinical events.

8. Executive Recommendations

Prioritize chronic disease management — hypertension, diabetes, and hyperlipidemia drive diagnoses and medications across the cohort.
Focus readmission reduction on emergency and observation pathways — 19.3% rate concentrated in EW EMER. and observation admits.
Plan capacity around ED throughput and transfer volume — 236 ED events and 404 intra-hospital transfers signal active bed management.
Separate admission volume from bed-day intensity — high-utilizer patients and URGENT admissions drive LOS, not EW EMER. volume alone.
Use the pipeline as a scalable template — extend medallion architecture, Gold views, and Power BI pattern to full MIMIC-IV or production hospital feeds.